Post-effective amendment to a registration statement that is not immediately effective upon filing

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Financing activities    
Cash and Restricted Cash, Beginning of Period   $ 179,512
P3 Health Partners Inc.    
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor
Net loss attributable to Class A common stockholders - Diluted $ (963,896,193) $ (54,115,119)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Depreciation and Amortization 43,471,912 762,378
Stock-Based Compensation 15,426,980 1,024,307
Goodwill impairment 851,455,754 0
Amortization of Debt Origination Fees   349,324
Amortization of Discount from Issuance of Debt   621,305
Mark-to-Market Adjustment of Stock Warrants (5,953,817) 10,661,579
Premium Deficiency Reserve (2,814,084) 3,000,000
Changes in Assets and Liabilities:    
Non-cash Interest Expense 187,599  
Accounts Receivable (376,219) 92,491
Health Plan Receivables / Premiums (49,555,406) 1,212,093
Other Current Assets 1,890,414 (361,241)
Net Change in ROU Assets and Liabilities 3,556,272 75,337
Accounts Payable 1,163,574 (1,005,876)
Accrued Payroll (3,041,024) (2,648,873)
Accrued Interest 2,558,865 1,807,007
Health Plan Payables / Premiums (4,526,299) (1,342,803)
Claims Payable 37,364,043 5,736,206
Net Cash used in Operating Activities (73,087,629) (34,131,885)
Cash Flows from Investing activities    
Purchase of Property, Plant and Equipment (1,400,511) (1,883,226)
Acquisitions   (82,000)
Increase in Notes Receivable, Net   226,808
Net Cash used in Investing Activities (1,400,511) (1,738,418)
Cash Flows From Financing activities    
Issuance of Long-Term Debt   12,750,000
Repayment of Short-Term and Long-Term Debt (2,446,433) (44,629)
Loan Origination and Closing Fees   (191,250)
Net Cash used in (provided by) Financing Activities (2,446,433) 12,514,121
Net Change in Cash and Restricted Cash (76,934,573) (23,356,182)
Cash and Restricted Cash, Beginning of Period 140,833,872 39,902,947
Cash and Restricted Cash, End of Period $ 63,899,299 $ 16,546,765